Proposals for further consideration by the Friend of the Chair on Investigations

ANNUAL DECLARATIONS

APPENDIX B

DECLARATION OF DEFENSIVE BIOLOGICAL AND TOXIN PROGRAMMES AND/OR ACTIVITIES CONDUCTED DURING THE PREVIOUS YEAR

1. Name of State Party:

...............................................................................................................................................................................................

2. This declaration relates to the calendar year:

...............................................................................................................................................................................................

3. At any time in the declaration year, have you conducted any programmes and/or activities as specified in Article III, section D, subsection I, paragraph 9?

YES / NO

If yes, complete the [remainder of this format] [respective biodefence facility formats].

[4. Did any of the programmes and/or activities continue until the end of the declaration year:

YES / NO]

[5. Describe the general objectives of any such programmes and/or activities specified in Article III, section D, subsection I, paragraph 9 (50 lines or less):

...............................................................................................................................................................................................

6.⁴⁹ Indicate by ticking the appropriate box whether any work has been carried out in the following areas:

Work area	Research and development [(including testing and evaluation)]	[Testing or evaluation]	[Production other than in research, development, testing or evaluation]
Detection or diagnosis
Decontamination			n.a.
Prophylaxis against disease
[Physical protection]			n.a.
Treatment of disease Pathogenicity or virulence			n.a.
[Genetic modification]			n.a
. [Other characteristics of agents]			n.a.
Toxinology*			n.a.
[Toxicity other than relating to toxins]			n.a.
Aerobiology			n.a.
[Vector (e.g. insect) ecology]			n.a.
[Fermentation]
[Other related activities]

* Toxinology is the study of toxins.

7. Summarize the principal objectives of and the work performed in the programmes and/or activities in the areas indicated in question 6 above [, including special reference to work described under “other characteristics of agents” or “other related activities”]:

...............................................................................................................................................................................................

As an aggregate for the programmes and/or activities in the areas indicated in question 6 above, state for the reporting period:

8. Funding

[(a) The total funding:

..................................................................................................................................................................................

(b) Affiliation of sources of funding (tick all that apply):

9 Defence Ministry/Department/Agency

9 wholly

9 partially

9 Other government ministry/department/ agency

9 wholly

9 partially

9 Non-government

9 wholly

9 partially

9 International organization

9 wholly

9 partially

(c) Whether aspects of the work were conducted under contract with, or by, any of the following types of organization (tick any that apply):

. . . Industry . . . Academia . . . Government ministry/department/agency other than defence or military

If yes, indicate the percentage of the total funding that was expended in such organizations for this purpose (Estimates of percentages shall be rounded up to the nearest whole number):

[. . . Less than 5% . . . 5-25% . . . 26-50% . . . 51-75% . . . 76-100%]

[. . . 0-25% . . . 26-50% . . . 51-75% . . . 76-100%]

[Summarize the objectives of any such work:

...............................................................................................................................................................................................

9. For the personnel employed, including those contracted for more than six months:

[(a) Indicate the total number of personnel:

[ ___ 1-10 ___ 11-25 ___ 26-100 ___ 101-500 ___ greater than 500]

[ ___ 1-50 ___ greater than 50]]

[(b) Indicate the total person years of work (Where a fraction of a person year is involved, this shall be rounded up to the nearest whole number):

[ ___ 1-10 ___ 11-25 ___ 26-100 ___ 101-500 ___ greater than 500]

[ ___ 1-50 ___ greater than 50]]

[(c) Give a detailed break-down of the following personnel categories taking part in the activities and/or programmes:

	Scientific personnel including engineers	Technical assistance personnel
[Military] personnel
[Civilian personnel]
Contract personnel*

* Contract employees who have worked for more than six months in the reporting period. ]

[(c) Estimate the percentage of person-years that are full-time active duty military (Estimates of percentages shall be rounded up to the nearest whole number):

___ none ___ 1 - 25 per cent ___ 26 - 50 per cent ___ 51 - 75 per cent ___ 76 - 100 per cent

(c) bis Estimate the percentage of person-years that are full-time civilian defence ministry/department/agency employees (include on-site contractors) (Estimates of percentages shall be rounded up to the nearest whole number):

___ none ___ 1 - 25 per cent ___ 26 - 50 per cent ___ 51 - 75 per cent ___ 76 - 100 per cent ]

10. Indicate:

[(a) All biological agents and/or toxins they worked with:

..................................................................................................................................................................................]

[(a) bis All biological agents on which genetic modification was conducted to enhance pathogenicity, virulence, stability or resistance to antibiotics or chemical or physical methods of disinfection, or which altered the host range, the infection route or the ease of identification or diagnosis, within a high biological containment facility (BL3):

..................................................................................................................................................................................]

[(a) The types of pathogens and/or toxins worked on (tick any that apply):

Human or zoonotic pathogens:

. . . Bacteria . . . Viruses . . . Fungi . . . Others

Animal pathogens excluding zoonotic pathogens:

. . . Bacteria . . . Viruses . . . Fungi . . . Others

Plant pathogens:

. . . Bacteria . . . Viruses . . . Fungi . . . Others

Toxins: . . . ]

[(b) All agents and/or toxins listed in Annex A which were worked on, and for each indicate whether any genetic modification was performed:

Agent

Genetic modification performed (YES / NO) . . . . . . . . . . . .

In any such work, indicate any agents and/or toxins listed in Annex A which were worked on in any of the following types of organization:

Organizations in the declaring State Party:

Industry: agent(s): .........................................................................................................................................

Academia: agent(s): ......................................................................................................................................

Government ministry/department/agency other than defence or military: agent(s): .....................................................................................................................................................................

Organizations in another State or State Party, working under contract or through collaboration:

Industry: agent(s): .........................................................................................................................................

Academia: agent(s): ......................................................................................................................................

Government ministry/department/agency other than defence or military: agent(s):..................................................................................................................................................................... ]

(c) Whether fermenters/bioreactors exceeding [25] litres in volume were used to produce pathogens, toxins or simulants:

YES / NO

[If yes, indicate the types of products made and the purpose:

Type of product

Purpose . . . . . . . . . . . . . . . . . .

Were any such fermenters/bioreactors located in any of the following types of organization (tick any that apply):

Organizations in the declaring State Party:

. . . Industry . . . Academia . . . Government ministry/department/agency other than defence or military

Organizations in another State or State Party, working under contract or through collaboration:

. . . Industry . . . Academia . . . Government ministry/department/agency other than defence or military]

(d) Whether vaccine or vaccine ingredients causing a specific and protective immune response were produced for the general public or for armed forces:

YES / NO

[If yes, provide the names of the facilities involved:

..................................................................................................................................................................................]

(e) Whether the programmes and/or activities were supported by outdoor studies of biological aerosols or their simulants:

YES / NO

[Were any such outdoor studies performed in any of the following types of organization (tick any that apply):

Organizations in the declaring State Party:

. . . Industry . . . Academia . . . Government ministry/department/agency other than defence or military

Organizations in another State or State Party, working under contract or through collaboration:

. . . Industry . . . Academia . . . Government ministry/department/agency other than defence or military]

11. Provide a list of all biological defence facilities [for which a declaration format (Appendix C) or a listing format (Appendix D) has been provided (tick the appropriate box)]:

Name of biological defence facility	A declaration format has been provided (Appendix C)	A listing format has been provided (Appendix D)
. . .
. . .

12. Provide a diagram of the organizational structure of the declared programmes and/or activities, describing the reporting relationships including all the facilities mentioned in question 11 above:

...............................................................................................................................................................................................

13. Describe the national publication policy for the declared programmes and/or activities:

...............................................................................................................................................................................................

]